Article Text

PDF
THU0119 Assessment of rheumatoid cachexia and its association with clinical, functional and therapeutic outcomes
  1. ALD Moro1,
  2. V Hax1,
  3. RCE Santo2,
  4. T Fighera3,
  5. W Kisaki2,
  6. CV Brenol1,
  7. RM Xavier1
  1. 1Rheumatology Service, Hospital de Clínicas de Porto Alegre
  2. 2Universidade Federal do Rio Grande do Sul
  3. 3Endocrinology Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Abstract

Background Rheumatoid arthritis (RA) is a chronic and inflammatory disease that besides articular symptoms leads to loss of muscle mass in presence of stable or increased fat mass (FM), condition defined as rheumatoid cachexia (RC). RC is associated with a worse prognosis, but it is still overlooked in clinical practice.

Objectives To evaluate the prevalence of rheumatoid cachexia (RC) in patients with rheumatoid arthritis (RA) and determine its correlation with the features of RA, the level of physical activity and with the current therapy.

Methods Ninety one RA patients in a cross-sectional study underwent total body dual-energy x-ray absorptiometry (DXA) for measurement of total and regional fat mass index (FMI; Kg/m2), lean mass index (LMI; Kg/m2), bone mineral content (BMC; Kg/m2) and fat free mass index (FFMI; Kg/m2) to assess the prevalence of RC. The associations of measures of body composition with RA features - age, diagnosis time, Health Assessment Questionnaire (HAQ), Disease Activity Score in 28 joints (DAS 28), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) -, level of physical activity (measured by International Physical Activity Questionnaire – IPAQ) and current therapy were explored.

Results Mean age was 56.8±7.3, disease duration 9 years (3 – 18), DAS28 3.65±1.32, HAQ 1.12 (0.25 – 1.87) and use duration of biological agents was 25 months (17.8 – 52.5). 17% of the patients had FFMI below the 10th percentile and FMI above the 25th percentile of a reference population and 33% of the patients had FFMI below the 25th percentile and FMI above the 50th percentile, condition known as RC, according to the more recently used definitions. FFMI correlated negatively only with age (r=-0.219; p=0.037) and disease duration (rs=-0.214; p=0.042). FMI correlated positively with CRP (rs=0.229; p=0.029), ESR (rs=0.235; p=0.025), DAS 28 (rs=0.273; p=0.009) and HAQ (rs=0.297; p=0.004). Among patients under biologics, 3.8% (n=1) had RC versus 23% (n=15) of those not taking biologics (p=0.033), according to the stricter definition.

Conclusions The prevalence of RC was considerable and deserves additional research. Besides that, patients under biological therapy had lower prevalence of RC, suggesting a protective effect of biological agents.

References

  1. Hugo M, Mehsen-Cetre N, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V. Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry. Rheumatology. 2016; 55(7): 1202–09.

  2. Masuko K. Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr 2014; 24: 1–20.

References

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.